Amneal Pharmaceuticals Future Growth

How is Amneal Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

4.0%

Forecasted annual revenue growth

Earnings and Revenue Growth Forecasts

NYSE:AMRX - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	2,470	170	N/A	368	4
12/31/2024	2,403	N/A	464	334	6
12/31/2023	2,313	N/A	481	332	6
9/30/2022	2,139	-132	53	152	N/A
6/30/2022	2,122	-134	80	140	N/A
3/31/2022	2,098	2	161	214	N/A
12/31/2021	2,094	11	189	242	N/A
9/30/2021	2,067	14	219	285	N/A
6/30/2021	2,058	9	176	247	N/A
3/31/2021	1,987	-17	408	478	N/A
12/31/2020	1,993	91	313	379	N/A
9/30/2020	1,880	62	183	222	N/A
6/30/2020	1,739	-194	283	317	N/A
3/31/2020	1,679	-199	71	159	N/A
12/31/2019	1,626	-362	-96	2	N/A
9/30/2019	1,727	-339	200	312	N/A
6/30/2019	1,825	-67	97	234	N/A
3/31/2019	1,834	-69	19	115	N/A
12/31/2018	1,663	-21	153	250	N/A
9/30/2018	1,459	155	-46	56	N/A
6/30/2018	1,237	149	-32	67	N/A
3/31/2018	1,083	168	83	192	N/A
12/31/2017	1,034	168	120	234	N/A
9/30/2017	1,039	54	84	205	N/A
12/31/2016	1,018	207	-10	115	N/A

Earnings vs Savings Rate: Insufficient data to determine if AMRX's forecast earnings growth is above the savings rate (2.1%).

Earnings vs Market: Insufficient data to determine if AMRX's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if AMRX's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: AMRX's revenue (4% per year) is forecast to grow slower than the US market (7.1% per year).

High Growth Revenue: AMRX's revenue (4% per year) is forecast to grow slower than 20% per year.

Future ROE: AMRX's Return on Equity is forecast to be very high in 3 years time (45.6%).